Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure

Bochra Tourki(University of South Florida), Ganesh V. Halade(University of South Florida), Vasundhara Kain(University of South Florida), Laurence M. Black(Pediatric Nephrology of Alabama)
Biomedicine & Pharmacotherapy
April 15, 2021
Cited by 12


Related Papers